Furthermore, Schayek et al. have indicated that hypermethylation of AR promoter in metastatic prostate cancer cells results in downregulation of IGF1R expression levels which indicates the fact that the IGF1R gene has been detected s a downstream target for AR action. This evidence concerns the gene IGF1R and prostate cancer.